This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Paul L R Andrews: Innovator in Gastro-Esophageal Reflux Treatment
Introduction
Paul L R Andrews is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the treatment of gastro-esophageal reflux disease. His innovative approach has led to advancements in understanding and treating this common condition.
Latest Patents
Andrews holds a patent for the "Use of GABAB receptor agonists in the screening of compounds which are reflux inhibitors." This invention relates to the use of GABA receptor agonists for the inhibition of transient lower esophageal sphincter relaxations. It aims to provide a new method for treating gastro-esophageal reflux disease, which affects many individuals worldwide. He has 1 patent to his name.
Career Highlights
Andrews is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmacology and treatment methodologies.
Collaborations
One of his notable coworkers is Anders Lehmann. Their collaboration has likely fostered innovative ideas and research that enhance the understanding of gastro-esophageal reflux disease and its treatment.
Conclusion
Paul L R Andrews is a distinguished inventor whose work has the potential to improve the lives of many suffering from gastro-esophageal reflux disease. His contributions to medical research and innovation are commendable and reflect his dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile